Aspen sees Mounjaro sales topping 124 million in 2027

Aspen Pharmacare forecasts African sales of Eli Lillys Mounjaro will exceed 124 million dollars in the current financial year. The projection comes as demand surges in South Africa with upcoming launches planned in Nigeria and Kenya.

Xurve View
Insights:
A box of Mounjaro, a tirzepatide injection drug used for treating type 2 diabetes and made by Lilly at Rock Canyon Pharmacy in Provo, Utah, U.S. March 29, 2023. REUTERS/George Frey

ASPEN PHARMACARE HOLDINGS LT expects African sales of ELI LILLY & CO's Mounjaro to exceed $124M in the 2027 financial year, driven by surging demand across South Africa. The expansion relies on planned regulatory approvals and commercial launches in Nigeria and Kenya during the current fiscal period.